Balyasny Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-567,389
Closed -$8.73M 3033
2025
Q4
$8.73M Buy
+567,389
New +$6.25M 0.01% 1094
2024
Q2
Sell
-137,600
Closed -$1.71M 2690
2024
Q1
$1.71M Buy
+137,600
New +$1.79M ﹤0.01% 1589
2023
Q4
Sell
-827,502
Closed -$12.2M 2571
2023
Q3
$12.2M Sell
827,502
-254,176
-23% -$3.57M 0.02% 772
2023
Q2
$14M Buy
+1,081,678
New +$12.3M 0.03% 651
2019
Q2
Sell
-57,737
Closed -$422K 1533
2019
Q1
$422K Sell
57,737
-58,097
-50% -$568K ﹤0.01% 1249
2018
Q4
$1.06M Buy
115,834
+63,509
+121% +$703K 0.01% 883
2018
Q3
$649K Buy
52,325
+41,225
+371% +$558K ﹤0.01% 1301
2018
Q2
$169K Buy
+11,100
New +$192K ﹤0.01% 1660

Other funds holding DVAX

Balyasny Asset Management's DVAX Position: Q1 2026 in Review

Balyasny Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 567,389 shares — an estimated $8.73M sold.

Balyasny Asset Management first reported a position in DVAX in Q2 2018 and held it in 8 quarters. The position peaked at $14M in Q2 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Balyasny Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 567,389 Dynavax Technologies shares in Q1 2026, an estimated $8.73M.
  • Balyasny Asset Management first reported a position in Dynavax Technologies in Q2 2018 and held it in 8 quarters.
  • Balyasny Asset Management's Dynavax Technologies position peaked at $14M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.